R&D at other companies
Other financials
Where this comes from
Reported directly by Envoy Medical in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The official record: Envoy Medical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Envoy Medical's r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Envoy Medical's R&D?
- Envoy Medical (COCH) reported R&D of $3.64M in Q1 2026.
- How has Envoy Medical's R&D changed year-over-year?
- Envoy Medical's R&D increased by 32.5% year-over-year, from $2.75M to $3.64M.
- What is the long-term trend for Envoy Medical's R&D?
- Over 2 years (2023 to 2025), Envoy Medical's R&D has grown at a 17.9% compound annual growth rate (CAGR), from $8.99M to $12.49M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.